drugset / Trial / NCT00955552

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee

NCT00955552 ↗

Phase 3 Completed 100 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of glucosamine and chondroitin sulfate association in the treatment of patients with osteoarthrosis of the knee.

Timeline

Start
2010-08
Primary completion
2011-02
Completion
2011-06

Outcome

Results reported · no primary-endpoint met/missed verdict (typical of a dose-finding / safety study)

paper the lower limit of the 90% confidence interval (CI) between the two groups (- 8.39%) was higher than the established margin of non-inferiority of - 10.00%. PMID 30657100 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin Unknown 400 mg Oral
Subject Glucosamine Small molecule 500 mg Oral

Indications